CABT-B10813

antibody from Creative Diagnostics
Targeting: NOG SYM1, SYNS1
Provider product page for CABT-B10813
No application information provided.

Antibody data

Product number
CABT-B10813 - Provider product page
Provider
Creative Diagnostics
Product name
Mouse anti-Human NOG monoclonal antibody, clone 4B3
Antibody type
Monoclonal
Description
The secreted polypeptide, encoded by this gene, binds and inactivates members of the transforming growth factor-beta (TGF-beta) superfamily signaling proteins, such as bone morphogenetic protein-4 (BMP4). By diffusing through extracellular matrices more efficiently than members of the TGF-beta superfamily, this protein may have a principal role in creating morphogenic gradients. The protein appears to have pleiotropic effect, both early in development as well as in later stages. It was originally isolated from Xenopus based on its ability to restore normal dorsal-ventral body axis in embryos that had been artificially ventralized by UV treatment. The results of the mouse knockout of the ortholog suggest that it is involved in numerous developmental processes, such as neural tube fusion and joint formation. Recently, several dominant human NOG mutations in unrelated families with proximal symphalangism (SYM1) and multiple synostoses syndrome (SYNS1) were identified
NOG protein structure - CABT-B10813 shown in red.